154.43
Glaukos Corp (GKOS) 最新ニュース
Form 144 GLAUKOS Corp For: 26 September By Investing.com - Investing.com Nigeria
A Glaukos (NYSE: GKOS) officer proposes selling 1,615 shares on September 25. - Stock Titan
Presbyopia Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | AbbVie, Orasis Pharma, Eyenovia, Glaukos Corp., Ocuphire Pharma, Novartis - Barchart.com
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now - Yahoo Finance
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo! Finance Canada
Glaukos Partners with NBA Champion Stephen Curry to Launch “Could - The National Law Review
Zacks Investment Research - globes.co.il
A Look at Glaukos Corp (GKOS) After 4.0% Decline -- GF Value $15 - gurufocus.com
Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $210 - moomoo.com
$1000 Invested In Glaukos 10 Years Ago Would Be Worth This Much Today - Benzinga
Stephen Curry is sharing his story to help families spot signs of a sight-threatening eye disease. - stocktitan.net
Glaukos (GKOS), Why Is It Back In The Spotlight? - Yahoo Finance
Glaukos Corporation (GKOS) Options ChainYahoo Finance - Yahoo! Finance Canada
GKOS Maintained by Jefferies -- Price Target Raised to $210 - GuruFocus
Glaukos stock gains institutional support as Bank of America builds position - AD HOC NEWS
Glaukos chief development officer Tomas Navratil sells $243k in shares - Investing.com
Glaukos Corp (GKOS) Stock Down 4.8% but Still Overvalued -- GF S - GuruFocus
Glaukos (NYSE: GKOS) officer lines up new stock sale after $2.48M August trade - Stock Titan
Glaukos Corp (GKOS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Cyclo3pss Corporation (CYPS) Peer Comparison – Compare with Others - Value Research
Glaukos Corp (GKOS) Shares Fall 5.2% -- What GF Score of 77 Tells Investors - GuruFocus
Why Glaukos Shares Are Trading Lower Today - Quiver Quantitative
If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Glaukos at Wells Fargo conference: launch ramps, reimbursement risks - Investing.com
Glaukos at Wells Fargo conference: launch ramps, reimbursement risks By Investing.com - Investing.com Canada
Is Glaukos Corp (GKOS) Overvalued After 4.3% Rally? GF Value Say - GuruFocus
Glaukos Corp (NYSE: GKOS) Share Price, GKOS Stock News, GKOS Share Price & Updates - Kalkine
ZimVie Inc. When-Issued (ZIMVV) Peer Comparison – Compare with Others - Value Research
Enterprise value to EBITDA forward of Glaukos Corp – LSX:A14VCK - TradingView
Precipio Inc. (PRPO) Peer Comparison – Compare with Others - Value Research
Mesa Laboratories Inc. (MLAB) Peer Comparison – Compare with Others - Value Research
Bruker Corporation (BRKR) Peer Comparison – Compare with Others - valueresearchonline.com
Haemonetics Corporation (HAE) Peer Comparison – Compare with Others - Value Research
Repligen Corporation (RGEN) Peer Comparison – Compare with Others - valueresearchonline.com
Quidel Corporation (QDEL) Peer Comparison – Compare with Others - Value Research
Heska Corporation (HSKA) Peer Comparison – Compare with Others - Value Research
UFP Technologies Inc. (UFPT) Peer Comparison – Compare with Others - Value Research
Innovative Eyewear Inc (LUCYW) Peer Comparison – Compare with Others - Value Research
Natus Medical Incorporated (NTUS) Peer Comparison – Compare with Others - Value Research
Repro Med Systems Inc. (KRMD) Peer Comparison – Compare with Others - Value Research
TransMedics Group Inc. (TMDX) Peer Comparison – Compare with Others - Value Research
Allied Healthcare Products Inc. (AHPI) Peer Comparison – Compare with Others - Value Research
Codex DNA Inc (DNAY) Peer Comparison – Compare with Others - Value Research
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - Value Research
AtriCure Inc. (ATRC) Peer Comparison – Compare with Others - valueresearchonline.com
IsoPlexis Corporation (ISO) Peer Comparison – Compare with Others - Value Research
Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - Value Research
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
Glaukos chief development officer sells $2.48m in shares By Investing.com - Investing.com Nigeria
Glaukos chief development officer sells $2.48m in shares - Investing.com
Glaukos stock trades at $179 as investors weigh recent growth and valuation - AD HOC NEWS
Xtant Medical Holdings Inc. (XTNT) Peer Comparison – Compare with Others - Value Research
ICU Medical Inc. (ICUI) Peer Comparison – Compare with Others - Value Research
Trinity Biotech plcADR Peer Comparison – Compare with Others - Value Research
Acutus Medical Inc (AFIB) Peer Comparison – Compare with Others - Value Research
Penumbra Inc. (PEN) Peer Comparison – Compare with Others - Value Research
SS Innovations International Inc. (SSII) Peer Comparison – Compare with Others - Value Research
Glaukos Corp (GKOS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Bioventus Inc. Class A (BVS) Peer Comparison – Compare with Others - Value Research
Aethlon Medical Inc. (AEMD) Peer Comparison – Compare with Others - Value Research
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
大文字化:
|
ボリューム (24 時間):